MedPath

Karolinska Institutet

Karolinska Institutet logo
🇧🇪Belgium
Ownership
Private
Established
1810-01-01
Employees
1K
Market Cap
-
Website
http://www.ki.se

ADHD Medication Benefits Diminish as Prescription Rates Rise, Swedish Study Reveals

A Swedish population study of 247,420 individuals found that ADHD medications consistently reduced risks of self-harm, unintentional injury, traffic crashes, and crime across all age groups and sexes.

Varenicline-Bupropion Combination Shows Promise for Alcohol Use Disorder Treatment

A 13-week randomized trial of 384 patients with moderate to severe alcohol use disorder found that combining varenicline and bupropion produced approximately twice the effect of currently available medications.

Alamar Biosciences Partners with SciLifeLab to Advance Precision Proteomics for Early Disease Detection

Alamar Biosciences has announced a strategic collaboration with Sweden's SciLifeLab to advance translational proteomics and accelerate biomarker discovery for early disease detection.

Belimumab Shows Superior Efficacy for Systemic Lupus Erythematosus in Meta-Analysis

A comprehensive meta-analysis of five randomized controlled trials confirms belimumab's superior efficacy over placebo in treating systemic lupus erythematosus (SLE) according to BICLA criteria.

Johnson & Johnson and Karolinska Institutet Celebrate Decade of Collaboration Advancing Medical Innovations

The ten-year partnership between Johnson & Johnson Innovative Medicine and Karolinska Institutet has yielded significant scientific advances across nine disease areas, with researchers working side by side since 2015.

Nanorobots for Drug Delivery Market Set to Reach $1.73 Billion by 2030, Transforming Precision Medicine

The global nanorobots for drug delivery market is projected to grow from $1.22 billion in 2025 to $1.73 billion by 2030, representing a CAGR of 7.05% as demand for targeted therapeutic solutions increases.

DiviTum® TKa Blood Test Shows Promise in Predicting Immunotherapy Response Across Multiple Cancers

New research from Karolinska Institutet demonstrates that Biovica's DiviTum® TKa blood test, when combined with inflammation protein biomarkers, significantly improves prediction of immunotherapy efficacy in melanoma patients.

Study Reveals Why Children's Cancer Immunotherapy Differs From Adults, Opening Path to Precision Medicine

Researchers at Karolinska Institutet discovered that children's tumors are less inflammatory and have fewer mutations than adults', explaining their reduced response to immunotherapy treatments.

Single-Dose HPV Vaccine Shows Promise in Long-Term Cervical Cancer Prevention Study

A landmark 17-year Swedish study of 2.2 million females reveals that one or two doses of HPV vaccine before age 17 provide similar protection against severe cervical lesions as the standard three-dose regimen.

Self-Collected HPV Tests Poised to Reshape Cervical Cancer Screening

• New guidelines propose self-collected HPV tests for cervical cancer screening, potentially increasing early detection and access to care. • A new study suggests HPV self-test results can stratify women into risk groups, optimizing follow-up and colposcopy referrals. • Risk stratification using HPV variants and viral load could streamline screening in resource-limited settings, improving efficiency. • Forecasts predict a rise in diagnosed cervical cancer cases due to increased screening, emphasizing the need for thorough data analysis.

© Copyright 2025. All Rights Reserved by MedPath